Beyond Air Stock Soars as FDA Grants Orphan Drug Status for Glioblastoma Therapy
Alright, folks, let’s talk about a stock that’s lighting up the market today—Beyond Air, Inc. (NASDAQ: XAIR). As of this writing, this biotech is making waves, with its share price rocketing up nearly 100% in early trading. Why the fireworks? The big news dropped...